X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BNTC

Closed

Benitec Biopharma Ltd Adr

12.11
+0.41 (+3.50%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 11.7
Day's Range: 11.215 - 12.5
Send
When Written:
 
0.2099
Benitec Biopharma Ltd ADR is a biotechnology company that focuses on the development of RNA interference (RNAi) therapeutics for the treatment of various diseases. The company's proprietary gene-silencing technology, called ddRNAi, targets and silences specific genes that are involved in the development and progression of diseases such as hepatitis C, HIV, and cancer. Benitec Biopharma's lead product candidate, BB-301, is being developed for the treatment of oculopharyngeal muscular dystrophy (OPMD), a rare genetic disorder that affects the muscles used for swallowing and speaking. The company is headquartered in Sydney, Australia, and its ADRs trade on the NASDAQ under the ticker symbol "BNTC."

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X